ABVC BioPharma, Inc. (ABVC) Ownership
ABVC ownership summary
as of October 17, 2026- Institutions
- 4.1% of shares outstanding
- Insiders
- 18.09% of shares outstanding
- Shares outstanding
- 26.7M
- Float
- 21.1M shares available to trade
- Short interest
- 2.24% 490K shares short
- Days to cover
- 3.64 short interest down 2.9% vs prior month
- Institutions 4.08%
- Insiders 18.09%
- Other investors 77.83%
ABVC top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard Capital Management, LLC | 1.40% | 374K | $343,790 | +183,925 (+96.5%) | June 30, 2026 |
| 2 | Geode Capital Management, LLC | 0.85% | 228K | $209,343 | +6,873 (+3.1%) | June 30, 2026 |
| 3 | Vanguard Fiduciary Trust Co | 0.36% | 97K | $89,379 | — | June 30, 2026 |
| 4 | State Street Corp | 0.27% | 73K | $66,830 | — | June 30, 2026 |
| 5 | Citadel Advisors Llc | 0.27% | 72K | $66,180 | +72,091 (0.0%) | June 30, 2026 |
| 6 | BlackRock Inc | 0.21% | 56K | $51,814 | — | June 30, 2026 |
| 7 | Northern Trust Corp | 0.18% | 49K | $44,654 | +16,556 (+51.6%) | June 30, 2026 |
| 8 | XTX Topco Ltd | 0.18% | 48K | $44,317 | +48,276 (0.0%) | June 30, 2026 |
| 9 | Panagora Asset Management Inc | 0.14% | 37K | $33,674 | +36,682 (0.0%) | June 30, 2026 |
| 10 | UBS Group AG | 0.13% | 34K | $31,325 | +32,352 (+1,826.8%) | June 30, 2026 |
| 11 | Jane Street Group LLC | 0.08% | 20K | $18,414 | +20,059 (0.0%) | June 30, 2026 |
| 12 | Citigroup Inc | <0.01% | 540 | $496 | +540 (0.0%) | June 30, 2026 |
| 13 | LifeSteps Financial, Inc. | <0.01% | 300 | $275 | +300 (0.0%) | June 30, 2026 |
| 14 | Royal Bank of Canada | <0.01% | 17 | $16 | — | June 30, 2026 |
| 15 | Caitong International Asset Management Co., Limited. | 0.00% | 6 | $6 | +6 (0.0%) | June 30, 2026 |
| 16 | Tower Research Capital LLC | 0.00% | — | — | −5,423 (−100.0%) | June 30, 2026 |
| 17 | SIMPLEX TRADING, LLC | 0.00% | — | — | −196 (−100.0%) | March 31, 2026 |
| 18 | Dimensional Fund Advisors, Inc. | 0.00% | — | — | −12,227 (−100.0%) | June 30, 2026 |
| 19 | Renaissance Technologies Corp | 0.00% | — | — | −95,100 (−100.0%) | June 30, 2026 |
| 20 | Morgan Stanley - Brokerage Accounts | 0.00% | — | — | −5,175 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 11 holders added 418K shares and 5 cut 118K.
ABVC top mutual fund and ETF holders
5 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 1.35% | 361K | $331,280 | — | August 31, 2026 |
| 2 | Fidelity Extended Market Index | 0.41% | 109K | $99,958 | −585 (−0.5%) | August 31, 2026 |
| 3 | Fidelity Series Total Market Index | 0.13% | 36K | $32,617 | — | August 31, 2026 |
| 4 | Fidelity Total Market Index | 0.12% | 31K | $28,507 | — | August 31, 2026 |
| 5 | Fidelity Nasdaq Composite Index | 0.06% | 15K | $13,605 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
ABVC shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns ABVC
Institutional investors own 4.1% of ABVC BioPharma's shares and insiders 18.09%. The largest holder is Vanguard Capital Management, LLC with 1.40% of the shares (374K), as of June 30, 2026. Among the top 20 institutions, 11 added shares and 5 reduced their stake in the latest filings. Short interest is 2.24% of the float, or 3.64 days of average trading volume. The share count rose 1,223,931.6% since 2014.
Related: ABVC key metrics. See the ABVC stock overview for the latest quote and news.
ABVC ownership FAQ
Who owns the most ABVC BioPharma stock?
The largest shareholders of ABVC BioPharma are Vanguard Capital Management, LLC (1.40%), Geode Capital Management, LLC (0.85%), Vanguard Fiduciary Trust Co (0.36%), State Street Corp (0.27%), Citadel Advisors Llc (0.27%).
What percentage of ABVC BioPharma is owned by institutions?
Institutions hold 4.1% of ABVC BioPharma's shares outstanding; insiders hold 18.09%.
Which funds own ABVC BioPharma?
The largest fund holders of ABVC BioPharma are Vanguard MStar Total Stk Mkt Idx Invest (1.35%), Fidelity Extended Market Index (0.41%), Fidelity Series Total Market Index (0.13%), Fidelity Total Market Index (0.12%), Fidelity Nasdaq Composite Index (0.06%).
What is ABVC BioPharma's short interest?
490K shares of ABVC BioPharma were sold short, 2.24% of the float; at the average daily volume it would take 3.64 days to cover.
How many shares of ABVC BioPharma are outstanding?
ABVC BioPharma has 26.7M shares outstanding, of which 21.1M are in the public float.